Rossari Biotech Ltd (ROSSARI) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003405,
    "name": "Rossari Biotech",
    "stock_name": "Rossari Biotech",
    "full_name": "Rossari Biotech Ltd",
    "name_url": "stocks-analysis/rossari-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "528.80",
    "chg": 16.25,
    "chgp": "3.17%",
    "dir": 1,
    "prev_price": "512.55",
    "mcapval": "2,849.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543213,
    "symbol": "ROSSARI",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE02A801020",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "2.14 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/rossari-biotech-1003405-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Rossari Biotech Valuation Shifts to Very Attractive Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-valuation-shifts-to-very-attractive-amid-market-challenges-3997908",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/RossariBiotechL_valuationdot_3997908.png",
        "date": "2026-05-19 08:02:37",
        "description": "Rossari Biotech Ltd, a small-cap player in the Specialty Chemicals sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite recent share price pressures and a challenging industry backdrop, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling entry points relative to its historical averages and peer group, signalling a potential opportunity for discerning investors."
      },
      {
        "title": "Rossari Biotech Gains 13.49%: 2 Key Factors Driving the Weekly Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-gains-1349-2-key-factors-driving-the-weekly-surge-3983081",
        "imagepath": "",
        "date": "2026-05-09 12:02:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.480.15</p>\n                    <p><strong>6 May:</strong> Stock gains 2.01% amid rising volumes</p>\n                    <p><strong>7 May:</strong> Intraday high of Rs.526.90 with 10.65% close gain</p>\n                    <p><strong>8 May:</strong> Technical momentum shifts amid mixed signals, closes at Rs.544.90 (+0.98%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.480.15</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.544.90</div><div class=\"sta..."
      },
      {
        "title": "Rossari Biotech Ltd Surges 10.87% to Day's High of Rs 526.9 — Outperforms Sector by 7.16 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-ltd-hits-intraday-high-with-1087-surge-on-7-may-2026-3979445",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/RossariBiotechL_priceRelatedfactors_3979445.png",
        "date": "2026-05-07 10:01:09",
        "description": "The Sensex edged up a mere 0.03% on 7 May 2026, while Rossari Biotech Ltd surged 10.87%, marking a standout session in the Specialty Chemicals sector with a 7.16 percentage-point outperformance. This sharp intraday gain rewrites the short-term narrative for the stock, which has been on a five-day winning streak, raising questions about the sustainability of this momentum."
      },
      {
        "title": "Rossari Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rossari-biotech-ltd-is-rated-sell-3977549",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/RossariBiotechL_mojoScore_3977549.png",
        "date": "2026-05-06 10:10:40",
        "description": "Rossari Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Rossari Biotech Ltd Surges 9.18% to Day's High of Rs 508.85 — Outperforms Sector by 7.53 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-ltd-hits-intraday-high-with-918-surge-on-30-apr-2026-3970302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RossariBiotechL_priceRelatedfactors_3970302.png",
        "date": "2026-04-30 14:01:02",
        "description": "The Sensex declined by 0.38% on 30 Apr 2026, while Rossari Biotech Ltd surged 9.18%, outperforming its Specialty Chemicals sector by 7.53 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop."
      },
      {
        "title": "Rossari Biotech Ltd Faces Technical Momentum Shift Amid Bearish Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-ltd-faces-technical-momentum-shift-amid-bearish-trends-3969508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RossariBiotechL_technicaldot_3969508.png",
        "date": "2026-04-30 08:03:25",
        "description": "Rossari Biotech Ltd, a specialty chemicals company, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s technical indicators reveal a nuanced picture that investors should carefully analyse amid a challenging market backdrop."
      },
      {
        "title": "Rossari Biotech Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-ltd-faces-bearish-momentum-amid-technical-downturn-3967539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RossariBiotechL_technicaldot_3967539.png",
        "date": "2026-04-29 08:03:52",
        "description": "Rossari Biotech Ltd, a small-cap player in the specialty chemicals sector, has experienced a marked shift in price momentum and technical indicators, signalling a deteriorating outlook. The stock’s recent 7.51% decline to ₹468.15, coupled with a downgrade in its Mojo Grade from Hold to Sell, reflects growing bearish sentiment among investors and analysts alike."
      },
      {
        "title": "Are Rossari Biotech Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-rossari-biotech-ltd-latest-results-good-or-bad-3967141",
        "imagepath": "",
        "date": "2026-04-28 19:15:25",
        "description": "Rossari Biotech Ltd's latest financial results for Q4 FY26 present a mixed picture. The company reported consolidated net sales of ₹684.86 crores, reflecting a sequential growth of 17.74% and an 18.17% increase year-on-year. This performance indicates resilience in revenue generation, although it represents a deceleration compared to the company's historical growth trajectory, which has averaged a five-year CAGR of 28.63%. \n\nOn the profit side, consolidated net profit reached ₹45.97 crores, marking a significant sequential increase of 40.28% and a year-on-year growth of 33.48%. However, this profit surge was significantly bolstered by exceptional other income of ₹19.07 crores, raising questions about the sustainability of such earnings quality in future periods. \n\nDespite these positive headline figures, the operating margin (excluding other income) declined to 11.28%, down from 11.84% in the previous quart..."
      },
      {
        "title": "Rossari Biotech Ltd Hits Intraday Low Amid Price Pressure on 28 Apr 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-ltd-hits-intraday-low-amid-price-pressure-on-28-apr-2026-3966842",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/RossariBiotechL_priceRelatedfactors_3966842.png",
        "date": "2026-04-28 15:31:03",
        "description": "Rossari Biotech Ltd experienced a significant intraday decline on 28 Apr 2026, touching a low of Rs 464.5, down 8.23% from previous levels. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure amid a cautious market environment."
      }
    ],
    "total": 15,
    "sid": "1003405",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/rossari-biotech-1003405"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Jun-2026",
      "details": "Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "29-May-2026",
      "details": "Annual Secretarial Compliance Report for the Financial Year 2025-26.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "21-May-2026",
      "details": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Rossari Biotech Ltd has declared <strong>25%</strong> dividend, ex-date: 16 Aug 24",
          "dt": "2024-08-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Rossari Biotech Valuation Shifts to Very Attractive Amid Market Challenges

2026-05-19 08:02:37

Rossari Biotech Ltd, a small-cap player in the Specialty Chemicals sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite recent share price pressures and a challenging industry backdrop, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling entry points relative to its historical averages and peer group, signalling a potential opportunity for discerning investors.

Rossari Biotech Gains 13.49%: 2 Key Factors Driving the Weekly Surge

2026-05-09 12:02:19

Key Events This Week 4 May: Week opens at Rs.480.15 6 May: Stock gains 2.01% amid rising volumes 7 May: Intraday high of Rs.526.90 with 10.65% close gain 8 May: Technical momentum shifts amid mixed signals, closes at Rs.544.90 (+0.98%) Week OpenRs.480.15 Week CloseRs.544.90<div class="sta...

Rossari Biotech Ltd Surges 10.87% to Day's High of Rs 526.9 — Outperforms Sector by 7.16 Percentage Points

2026-05-07 10:01:09

The Sensex edged up a mere 0.03% on 7 May 2026, while Rossari Biotech Ltd surged 10.87%, marking a standout session in the Specialty Chemicals sector with a 7.16 percentage-point outperformance. This sharp intraday gain rewrites the short-term narrative for the stock, which has been on a five-day winning streak, raising questions about the sustainability of this momentum.

Rossari Biotech Ltd is Rated Sell

2026-05-06 10:10:40

Rossari Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Rossari Biotech Ltd Surges 9.18% to Day's High of Rs 508.85 — Outperforms Sector by 7.53 Percentage Points

2026-04-30 14:01:02

The Sensex declined by 0.38% on 30 Apr 2026, while Rossari Biotech Ltd surged 9.18%, outperforming its Specialty Chemicals sector by 7.53 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.

Rossari Biotech Ltd Faces Technical Momentum Shift Amid Bearish Trends

2026-04-30 08:03:25

Rossari Biotech Ltd, a specialty chemicals company, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s technical indicators reveal a nuanced picture that investors should carefully analyse amid a challenging market backdrop.

Rossari Biotech Ltd Faces Bearish Momentum Amid Technical Downturn

2026-04-29 08:03:52

Rossari Biotech Ltd, a small-cap player in the specialty chemicals sector, has experienced a marked shift in price momentum and technical indicators, signalling a deteriorating outlook. The stock’s recent 7.51% decline to ₹468.15, coupled with a downgrade in its Mojo Grade from Hold to Sell, reflects growing bearish sentiment among investors and analysts alike.

Are Rossari Biotech Ltd latest results good or bad?

2026-04-28 19:15:25

Rossari Biotech Ltd's latest financial results for Q4 FY26 present a mixed picture. The company reported consolidated net sales of ₹684.86 crores, reflecting a sequential growth of 17.74% and an 18.17% increase year-on-year. This performance indicates resilience in revenue generation, although it represents a deceleration compared to the company's historical growth trajectory, which has averaged a five-year CAGR of 28.63%. On the profit side, consolidated net profit reached ₹45.97 crores, marking a significant sequential increase of 40.28% and a year-on-year growth of 33.48%. However, this profit surge was significantly bolstered by exceptional other income of ₹19.07 crores, raising questions about the sustainability of such earnings quality in future periods. Despite these positive headline figures, the operating margin (excluding other income) declined to 11.28%, down from 11.84% in the previous quart...

Rossari Biotech Ltd Hits Intraday Low Amid Price Pressure on 28 Apr 2026

2026-04-28 15:31:03

Rossari Biotech Ltd experienced a significant intraday decline on 28 Apr 2026, touching a low of Rs 464.5, down 8.23% from previous levels. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure amid a cautious market environment.

View All News